The purpose of the proof-of-concept study is to confirm that our electrically conductive, vertically aligned carbon nanofibers can function as an interconnect between an integrated circuit and a sensor material that is not compatible with metals.
We have been collaborating with the global medtech company for some time and a number of initial tests have already been performed. However, the current proof-of-concept study will include a more complete test of the concept, which among other things aims to verify the performance of the solution and to ensure that the assembly lasts, as well as to obtain more knowledge in how to scale up the concept to volume production.
“This is a great business opportunity for us, in a unique context where we don’t really see any alternative solutions. The medtech industry is very interesting as a potential business area for Smoltek’s future expansion, in addition to our two priority business areas: the semiconductor industry, where we develop ultra-thin capacitors for application processors and the hydrogen industry, where we develop high-performance cell materials for electrolyzers”says Smoltek’s CEO Håkan Persson
The carbon nanofiber technology used in this proof-of-concept study is very similar to what we are developing for our main business track – ultra-thin capacitors, and the study is an excellent example of the many areas where the company’s technology can be applied.
The order to carry out the proof-of-concept study is worth 40,000 euros.